|
|
||||||||
J Thorac Cardiovasc Surg 2009;137:394-403
© 2009 The American Association for Thoracic Surgery
Congenital Heart Disease |
a Mechanical and Aerospace Engineering Department, University of California, San Diego, Calif
b Electrical Engineering Department, Stanford University, Stanford, Calif
c Department of Cardiothoracic Surgery, Stanford University, Stanford, Calif
d Bioengineering Department, Stanford University, Stanford, Calif
e Mechanical Engineering Department, Stanford University, Stanford, Calif
f Department of Radiology, Stanford University, Stanford, Calif
g Department of Pediatrics, Stanford University, Stanford, Calif
Received for publication November 9, 2007; revisions received April 1, 2008; accepted for publication June 15, 2008. * Address for reprints: Alison L. Marsden, PhD, Mechanical and Aerospace Engineering, University of California San Diego, 9500 Gilman Drive, La Jolla, CA. (Email: amarsden{at}stanford.edu).
| Abstract |
|---|
|
|
|---|
Methods: The proposed design replaces the current tube grafts used to connect the inferior vena cava to the pulmonary arteries with a Y-shaped graft. Y-graft hemodynamics were evaluated at rest and during exercise with a patient-specific model from magnetic resonance imaging data together with computational fluid dynamics. Four clinically motivated performance measures were examined: Fontan pressures, energy efficiency, inferior vena cava flow distribution, and wall shear stress. Two variants of the Y-graft were evaluated: an "off-the-shelf" graft with 9-mm branches and an "area-preserving" graft with 12-mm branches.
Results: Energy efficiency of the 12-mm Y-graft was higher than all other models at rest and during exercise, and the reduction in efficiency from rest to exercise was improved by 38%. Both Y-graft designs reduced superior vena cava pressures during exercise by as much as 5 mm Hg. The Y-graft more equally distributed the inferior vena cava flow to both lungs, whereas the offset design skewed 70% of the flow to the left lung. The 12-mm graft resulted in slightly larger regions of low wall shear stress than other models; however, minimum shear stress values were similar.
Conclusions: The area-preserving 12-mm Y-graft is a promising modification of the Fontan procedure that should be clinically evaluated. Further work is needed to correlate our performance metrics with clinical outcomes, including exercise intolerance, incidence of protein-losing enteropathy, and thrombus formation.
| Introduction |
|---|
|
|
|---|
Recently, and concurrently with our work, Soerensen and associates13
proposed a similar design called the "OptiFlo" in which the native inferior (IVC) and superior venae cavae (SVC) are bifurcated before the pulmonary artery anastomosis. Their study demonstrated reduced power loss at rest and simulated exercise with simplified geometric models and steady inflow conditions. The two studies share the concept of eliminating flow competition by bifurcating the graft used in the extracardiac Fontan procedure. However, our study addresses some of the computational limitations of this previous study through the use of more detailed geometric models, pulsatile inflow conditions, and sophisticated outflow boundary conditions. In addition, our proposed Y-graft design offers several important technical advantages: it can be easily modified for an individual patient, it can be custom manufactured of synthetic material using realistic sizes, and it allows the procedure to be performed without cardiopulmonary bypass.
We11
have previously reported the development of an increasingly accurate Fontan modeling system, producing realistic pressure and flow data when compared with that measured by catheterization and echocardiography. This was accomplished by incorporating increased anatomic accuracy, specifically a greater level of pulmonary branching, and the effects of respiration and cardiac contraction. The simulation framework used in this work produces results including energy efficiency, absolute pressures, pressure gradients, wall shear stress (WSS), and flow distribution. Several important features of this software have been customized for cardiovascular applications and are not available in standard commercial codes. These include resistance, impedance and lumped model boundary conditions to accurately model physiologic pressure levels,14,15
Lagrangian particle-tracking methods, wall deformability (not used in this work),16
and adaptive meshing capabilities.17
Results from these patient-specific simulations suggest that despite seemingly excellent technical and hemodynamic results with current clinical markers and diagnostic modalities, marked differences in individual Fontan efficiencies exist. Additionally, during simulated exercise, efficiencies drop substantially, and differences in performance between geometries become more pronounced. These previous results demonstrated that studies focusing solely on resting conditions (and reporting resting efficiencies of 90% based on the ratio of energy outflow to inflow) were not comprehensive representations of the "physiologic realities" of the Fontan circulation and provided a strong impetus for increased study and design of more efficient Fontan geometries.
In this study, we describe and evaluate a new modification of the extracardiac Fontan procedure using computer-aided design and computational fluid dynamics. This modification incorporates a Y-shaped graft to replace the cylindrical polytetrafluoroethylene tube grafts (Gore-Tex; W. L. Gore & Associates, Inc, Flagstaff, Ariz) currently used to connect the IVC to the pulmonary arteries. We demonstrate that the Y-graft results in higher energy efficiency and more equal distribution of IVC flow to both left and right lungs when compared with current operative techniques.
| Methods |
|---|
|
|
|---|
Image/Anatomy Acquisition
Magnetic resonance angiography was performed with a 1.5-T magnetic resonance imaging (MRI) scanner (Signa TwinSpeed; General Electrics, Milwaukee, Wis). During intravenous administration of a gadolinium-based contrast agent, images were acquired using a half-Fourier, 3-dimensional fast gradient–recalled echo sequence with breath-holding. The spatial resolution was approximately 0.7 mm x 1.2 mm x 2.0 mm. Flow waveforms in the venae cavae were recorded with a 2-dimensional phase-contrast (PC) MRI method. The imaging plane was placed perpendicular to the dominant flow with velocity encoding parallel to the flow. The slice thickness was 10 mm and the in-plane resolution was about 1.0 mm x 1.7 mm. The encoding velocity was 120 cm/s. Velocity data were acquired over several cycles of free breathing with the use of cardiac gating and respiratory compensation.
Model Construction
Once the image data have been acquired, there are four steps necessary to construct geometric models from image data volumes (Figure 1
)19
(1) Centerline paths are created in the vessels of interest, (2) segmentations of the vessel lumen are created perpendicular to the centerlines using a 2-dimensional level set method, (3) the 2-dimensional segmentations are lofted together, creating a solid model of the desired vasculature, and (4) the solid model is discretized into an unstructured tetrahedron mesh for use in the finite element flow solver.
|
|
The first (small-Y) was constructed with an 18-mm trunk with two 9-mm branches, modeled after grafts that are approved by the Food and Drug Administration and currently available. The second (large-Y) was designed to approximately preserve the cross-sectional area between the trunk (18 mm) and two branches (each 12 mm). While an exact area preservation would result in 12.7-mm branches, the smaller size was chosen to achieve a better fit to the pulmonary arteries for this patient and because grafts are typically manufactured with standardized integer dimensions. The IVC trunk dimension of 18 mm was chosen in accordance with current practice at our institution. In a recent study of more than 300 patients, 97% received conduits of 18 mm or larger, and 69% received conduits of 20 mm or larger.9
These results also agree with previous studies determining optimal graft size.20
Flow Simulations and Boundary Conditions
To simulate blood flow, we used a custom stabilized finite element solver to solve the time-dependent, 3-dimensional Navier–Stokes equations.21,22
An anisotropic adaptive meshing scheme17
was used to ensure mesh convergence using approximately 1.5 million elements for each model. A newtonian approximation for the viscosity was assumed with a value of 0.04 g/(cm s) and the density of blood was 1.06 g/cm3. A rigid-wall approximation was used. Further details on our Fontan simulation methods and flow solver can be found in the article by Marsden and associates.11
Respiratory-varying boundary conditions were imposed at the IVC inlet in all simulations. Pulsatile flow rates were acquired from patient-specific PC-MRI data and were superimposed on a respiration model to construct inflow waveforms.11
Since little respiratory variation is observed in the SVC, the PC-MRI flow waveform was imposed at the SVC inflow face with no respiration model. The IVC and SVC flow waveforms were mapped to a parabolic profile on the inlet faces of the model.
Four flow rate levels were used in the IVC: normal/resting (ie, measured) flow and 2, 3, and 4 times normal flow to simulate light, moderate, and heavy exercise conditions. Although the heavy exercise condition may not be physically attainable by most Fontan patients, simulations allow us to push the limits of performance for evaluation purposes. Flow rates in the SVC were increased only for the highest level of exercise, by 50%.23
Table 1
lists the mean rest and exercise flow rates used in simulations for all models.
|
A 3-element windkessel model25
was assigned to each of the 20 outlets of the 3-dimensional model using the coupled multidomain method.14
The resistance and capacitance parameters were chosen so that the impedance of the windkessel model best fit the impedance of a morphometry-based pulmonary arterial tree constructed at each outlet of the Fontan model.15
At a given level of exercise, identical boundary conditions were imposed for all models considered in this study.
Each simulation was run on 20 to 24 processors of an SGI Altix parallel supercomputer (SGI, Sunnyvale, Calif), requiring about 1000 CPU hours (2 days) of run time. Simulation results were post-processed to interpret velocity, pressure, and WSS information throughout the model.
Energy Efficiency
Efficiency was calculated for each model at rest and all exercise levels by calculating the rate of energy passing through all inlets and outlets using the equations shown below. Since all models shared identical pulmonary branches as well as identical inflow and outflow boundary conditions, changes in efficiency result only from changes in Fontan geometry.
The energy dissipation (neglecting gravitational effects) is given by
|
| (1) |
is the density, Nin and Nout are the number of model inlets and outlets, respectively, and Ai is the area of the ith inlet or outlet.11,26|
| (2) |
IVC Flow Distribution
Particle-tracking methods27
were used to quantify the distribution of IVC flow to the right and left lungs. The inlet of the IVC was uniformly seeded with 35,000 particles every 1/50th of the respiratory cycle for an entire cycle. The particles were advected by the flow (Figure E1) until approximately all particles were flushed from the computational domain, requiring about two respiratory cycles. Particles were assumed to be massless, and effects of diffusion were neglected owing to the short residence time of the particles in the computational domain. The advection scheme used a Runge–Kutta–Fehlberg28
integration algorithm with a maximum error tolerance of 10–5 and a linear interpolation of the velocity data in space and time.
The proportion of IVC flow going to the left lung was quantified by summing the number of particles that exited the computational domain through outlets connected to the LPA. Likewise, the portion of IVC flow to the right lung was quantified by summing the number of particles that exited through outlets connected to the RPA. It was verified that the results were independent of the seeding density and rate and the integration error tolerance.
| Results |
|---|
|
|
|---|
|
|
Results from the t-junction simulations at rest verify that the pressure drop from the Fontan baffle to the LPA and RPA (<1 mm Hg) match the finding of "no significant pressure drops" reported during catheterization. Figure 5 quantifies the mean pressure levels in the IVC and SVC at rest and all levels of exercise for the four models. Pressures in the IVC were lowest with the large-Y model, although pressures in the offset design were only slightly higher. The small-Y IVC pressures were nearly as high as the t-junction Fontan. SVC pressures were substantially lower in both Y-graft models than in either the t-junction or the offset models. Differences in mean pressure among all models are small during rest but increase during exercise to nearly 5 mm Hg in the IVC and 3 mm Hg in the SVC. During moderate exercise, the differences in peak pressure between the t-junction and the large Y-graft are nearly 8 mm Hg in the SVC and 4 mm Hg in the IVC.
|
|
IVC Flow Distribution
Another presumed important determinant of performance is the relative distribution of IVC flow to the right and left lungs. The percentages of IVC flow going to the LPA and RPA for all simulations are given in Table 2
. While the total (IVC+SVC) 45/55 flow split is very closely enforced by the outflow boundary conditions in all cases, the relative distribution of SVC and IVC flow changes dramatically with the Fontan geometry. In the offset model, the majority of IVC flow is directed to the lung on the side of the offset, whereas most SVC flow goes to the opposite lung. In contrast, the Y-graft design evenly distributes both the IVC and SVC flow. The t-junction slightly favors the LPA side owing to a small asymmetry in the junction geometry in this particular patient.
|
|
| Discussion |
|---|
|
|
|---|
|
Additionally, most previous studies have used steady inflow conditions or have only included the cardiac pulsatility1–4,32
without considering respiration. In contrast, our respiratory model results in time-varying flow rates and pressures that are consistent with clinical observations. Both echocardiography tracings11
and real-time PC-MRI measurements31,33
have shown significant variation (as much as 80%) in Fontan IVC flow rates with respiration. Similar variation is found in pressure tracings from cardiac catheterization, and previous work using the respiration model demonstrated good agreement with pressure tracings from catheterization.11
The respiration model is used in combination with sophisticated outflow boundary conditions that allow for physiologic levels of pressure.14
With these capabilities, our simulation results are better matched to clinically observed flow rates and pressures than was possible in previous Fontan simulations.
A recent study by Soerensen and associates13
proposed a new TCPC geometry called the "OptiFlo" that bifurcates both the IVC and SVC. Our proposed Y-graft design and their OptiFlo design share the concept of avoiding direct IVC/SVC flow competition while maintaining symmetry of the TCPC junction. In addition, our Y-graft design is very similar to one of the alternate designs they propose, in which only the IVC is bifurcated. Both the Y-graft and OptiFlow designs demonstrate increased energy efficiency compared with current offset designs. From a modeling standpoint, the Y-graft simulations presented here address some limitations of those reported by Soerensen's group,13
including simplified geometries and steady inflow conditions.
There are a few key differences that distinguish the Y-graft design from the OptiFlo and make it more practical from a surgical standpoint. First, the proposed Y-graft would be custom manufactured of synthetic material, following current surgical practice for the extracardiac conduit.9
As currently proposed by Soerensen and associates,13
the OptiFlo would be created by bifurcating the patient's native vessel in both the SVC and IVC. This makes the assumption that the native IVC vessel will reach the pulmonary arteries without requiring a synthetic graft. As a result, the OptiFlo graft dimensions are much smaller than currently used grafts because of the assumption that the IVC tissue will grow. An additional advantage of the Y-graft design is that it can be optimized or modified for an individual patient by custom manufacturing the graft portion before surgery.
It is likely that the Y-graft efficiencies could be improved further by bifurcating the SVC, as proposed in the OptiFlo design. However, this would require an increased level of surgical complexity with modifications to both the Glenn and Fontan procedures, introduction of synthetic material in the SVC, and significantly more suturing. In contrast, our proposed Y-graft Fontan can be implemented with a pre-made IVC graft, does not interfere with the native SVC, and allows for the operation to be performed without cardiopulmonary bypass.9
To make a thorough comparison, analysis of the OptiFlo (which used cylindrical models and steady flow simulations) should be extended to include patient-specific geometries (including representative branches of the pulmonary arteries) and physiologic flow and pressure conditions in future work. Further optimization on the Y-graft should be performed, for example, using the methods presented by Marsden, Feinstein, and Taylor34
for optimization of cardiovascular geometries.
Pressure levels in the IVC and SVC are important measures of Fontan performance and are known to be important determinants of long-term outcomes, with elevated pressures often linked with poor outcomes. Pressure levels in both the IVC and SVC were significantly reduced with the new Y-graft design, even in the setting of presumed exceptional hemodynamics given the catheterization measured mean pressures of 7 mm Hg. The difference was particularly pronounced during exercise. The long-term effects of elevated IVC and SVC pressures on exercise intolerance and Fontan outcomes are not fully understood. Low Fontan pressures are generally indicative of better clinical outcomes, albeit far from any guarantee of positive long-term outcomes. The Y-graft design also offers the advantage that SVC pressure is decoupled from the IVC pressure so that SVC pressure can remain lower than IVC pressure during exercise. This effect was demonstrated by our exercise simulations.
These simulations also show a significant improvement in energy efficiency in the large Y-graft model when compared with the other models. Previous work by Marsden and colleagues11
has also demonstrated large differences in efficiency between patients with different Fontan geometries. Clinical studies will be needed to correlate improvements in efficiency with differences in exercise tolerance and long-term outcomes in Fontan patients. However, it is logical to assume that any increase in efficiency should, in theory, reduce the work load on the system and be beneficial to the patient. Although efficiency improvements of only a few percentages may initially seem insignificant, differences of only a few percentages are similar to the effects one might see with a doubling of the IVC flow rate from rest to exercise. This leads us to believe these differences do, in fact, have potential to be significant for improving exercise capacity for these patients.
Previous studies have shown that a yet undetermined hepatic factor is essential for normal lung development and that the lack of this factor can lead to the development of arteriovenous malformations.35,36
The distribution of IVC flow will affect the concentration of hepatic factor present in the lungs. Although it is not known what concentration is required for normal lung development, if all other factors are equal, it is clearly desirable to distribute the flow (and, additionally, the relative "work" required by each lung) as evenly as possible. The proposed large-Y design distributes the IVC flow according to the 45/55 flow split. In contrast, we have found that the distribution of IVC flow with the offset design is strongly skewed toward the side of the offset. The IVC flow distribution in the large-Y connection appears relatively robust to local asymmetries; however, the t-junction and small-Y geometries appear more sensitive to asymmetries, which result in moderate changes from the 45/55 distribution.
One theoretical concern raised by the Y-graft results is the potential for thrombus formation resulting from flow stasis. Previous studies have shown that anticoagulation (with either aspirin or warfarin sodium) improves outcomes postoperatively for Fontan patients and that the incidence of thrombus formation at varying locations is 10% to 20%, regardless of the type of Fontan surgery.37,38
Our results show that the Y-graft model has slightly larger areas of low shear, but that the minimum WSS values are similar in value to other designs. It is not currently known what minimum levels of shear or particle residence time are needed to prevent thrombosis. The areas of low WSS areas observed in the Y-graft at rest should be investigated further to evaluate this risk. Because the low shear areas are coincident with areas of high local curvature in the model, we believe it is likely that optimization of the Y-graft geometry could eliminate local areas of low shear while maintaining higher efficiency. This will be investigated in future work on Y-graft optimization, in which a more gradual tapering from trunk to branches could be implemented. An additional concern could be the development of hypoplasia or even discontinuity between the two limbs of the Y-graft. This also should be investigated further. However, the results presented here do not indicate any areas of low WSS in this region (Figure E2).
Technical limitations of the Y-graft procedure compared with current surgical techniques include the need for more suturing (and suture lines) and an increased level of complexity in performing the operation. Integration of the model into a volume rendering of the MRI data from the patient shows no compression of the pulmonary veins or other barriers to technical feasibility. We also note that the Y-graft design should not impose anatomic space requirements beyond what is already routinely done in either a right or left offset procedure with a larger diameter baffle. A potential advantage from a technical standpoint is that the Y-graft could be clamped on the left side during surgery to patch the LPA in cases of LPA stenosis.
| Limitations |
|---|
|
|
|---|
An additional limitation of this work is the use of rigid walls in our simulations. It is expected that adding vessel compliance to the model will slightly decrease the efficiencies we have reported because of added energy dissipation. However, we do not expect this to change the relative performance of the four Fontan designs considered in this work.
There is also a need for more data on pulmonary arterial physiology and pulmonary flow distribution in Fontan patients. In particular, the extent to which the distal pulmonary arteries of Fontan patients will dilate during exercise is unknown. In this study, resistance was reduced somewhat less than that of healthy children on the basis of the assumption that Fontan patients are, at baseline, vasodilated and have limited capacity for further pulmonary vasodilation. Additionally, further data are needed to better quantify the distribution of flow among the lung segments. When available, these data should be incorporated into future Fontan modeling studies.
| Conclusions |
|---|
|
|
|---|
| Figure E1 |
|---|
|
|
|---|
|
| Figure E2 |
|---|
|
|
|---|
|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. A. Feinstein, D. W. Benson, A. M. Dubin, M. S. Cohen, D. M. Maxey, W. T. Mahle, E. Pahl, J. Villafane, A. B. Bhatt, L. F. Peng, et al. Hypoplastic left heart syndrome current considerations and expectations. J. Am. Coll. Cardiol., January 3, 2012; 59(1 Suppl): S1 - S42. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baretta, C. Corsini, W. Yang, I. E. Vignon-Clementel, A. L. Marsden, J. A. Feinstein, T.- Y. Hsia, G. Dubini, F. Migliavacca, G. Pennati, et al. Virtual surgeries in patients with congenital heart disease: a multi-scale modelling test case Phil Trans R Soc A, November 13, 2011; 369(1954): 4316 - 4330. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pennati, C. Corsini, D. Cosentino, T.-Y. Hsia, V. S. Luisi, G. Dubini, and F. Migliavacca Boundary conditions of patient-specific fluid dynamics modelling of cavopulmonary connections: possible adaptation of pulmonary resistances results in a critical issue for a virtual surgical planning Interface Focus, June 6, 2011; 1(3): 297 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Rodefeld, B. Coats, T. Fisher, G. A. Giridharan, J. Chen, J. W. Brown, and S. H. Frankel Cavopulmonary assist for the univentricular Fontan circulation: von Karman viscous impeller pump J. Thorac. Cardiovasc. Surg., September 1, 2010; 140(3): 529 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Corno, C. Vergara, C. Subramanian, R. A. Johnson, T. Passerini, A. Veneziani, L. Formaggia, N. Alphonso, A. Quarteroni, and J. C. Jarvis Assisted Fontan procedure: animal and in vitro models and computational fluid dynamics study Interact CardioVasc Thorac Surg, May 1, 2010; 10(5): 679 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Neal and R. Kerckhoffs Current progress in patient-specific modeling Brief Bioinform, January 1, 2010; 11(1): 111 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Naito, M. Aoki, K. Matsuo, H. Nakajima, H. Aotsuka, and T. Fujiwara Intracardiac Fontan procedure for heterotaxy syndrome with complex systemic and pulmonary venous anomalies Eur J Cardiothorac Surg, January 1, 2010; 37(1): 197 - 203. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |